Safety and Efficacy of MT-1303 in Subjects With Moderate to Severe Active Crohn's Disease

Mise à jour : Il y a 5 ans
Référence : NCT02378688

Femme et Homme

Extrait

The primary objectives of the study are: - To evaluate the safety and tolerability of MT-1303 in subjects with moderate to severe active Crohn's Disease(CD) - To evaluate the clinical efficacy of MT-1303 in subjects with moderate to severe active CD.


Critère d'inclusion

  • Crohn’s Disease


Liens